Cutaneous Kaposi’s Sarcoma Following Long-Term Infliximab Treatment in a Patient with HIV-Negative Antibiotic-Dependent Chronic Pouchitis: Considerations on an Exceptional Finding

Cutaneous Kaposi’s Sarcoma Following Long-Term Infliximab Treatment in a Patient with HIV-Negative Antibiotic-Dependent Chronic Pouchitis: Considerations on an Exceptional Finding

In managing ulcerative colitis (UC), anti-tumour necrosis factor (TNF) agents are among the primary choices. Evidence suggests anti-TNF does not significantly increase malignancy risk (apart from lymphoma and melanoma), though uncertainties persist due to inconsistent long-term data. Kaposi’s sarcom...

Full description

Bibliographic Details
Main Authors: Raffaele Pellegrino, Giovanna Palladino, Francesca Pagliuca, Stefano Lucà, Alessandro Federico, Antonietta Gerarda Gravina
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Gastrointestinal Disorders
Subjects:
ulcerative colitis
TNF antagonists
Kaposi’s sarcoma
infliximab
immunosuppression
inflammatory bowel disease
Online Access:https://www.mdpi.com/2624-5647/6/4/69

Internet

https://www.mdpi.com/2624-5647/6/4/69

Similar Items